Mucosal Immunization with Iron Receptor Antigens Protects against Urinary Tract Infection
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Uncomplicated infections of the urinary tract, caused by uropathogenic Escherichia coli, are among the most common diseases requiring medical intervention. A preventive vaccine to reduce the morbidity and fiscal burden these infections have upon the healthcare system would be beneficial. Here, we describe the results of a large-scale selection process that incorporates bioinformatic, genomic, transcriptomic, and proteomic screens to identify six vaccine candidates from the 5379 predicted proteins encoded by uropathogenic E. coli strain CFT073. The vaccine candidates, ChuA, Hma, Iha, IreA, IroN, and IutA, all belong to a functional class of molecules that is involved in iron acquisition, a process critical for pathogenesis in all microbes. Intranasal immunization of CBA/J mice with these outer membrane iron receptors elicited a systemic and mucosal immune response that included the production of antigen-specific IgM, IgG, and IgA antibodies. The cellular response to vaccination was characterized by the induction and secretion of IFN-gamma and IL-17. Of the six potential vaccine candidates, IreA, Hma, and IutA provided significant protection from experimental infection. In immunized animals, class-switching from IgM to IgG and production of antigen-specific IgA in the urine represent immunological correlates of protection from E. coli bladder colonization. These findings are an important first step toward the development of a subunit vaccine to prevent urinary tract infections and demonstrate how targeting an entire class of molecules that are collectively required for pathogenesis may represent a fundamental strategy to combat infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6 Isotype class-switching and urinary IgA correlates with vaccine-mediated protection from infection. (A) The Class Switch Index was calculated by dividing the change in serum IgG absorbance for the entire group of vaccinated mice (accounting for non-specific increases by subtracting the corresponding median change in IgG absorbance for the CT-vaccinated mouse cohort) by the same computation preformed with group median IgM absorbance values [(ΔIgGVAC−ΔIgGCT)/(ΔIgMVAC−ΔIgMCT)]. The Class Switch Index was then plotted against the normalized bladder CFU (group median CFUVAC/group median CFUCT) for each vaccination experiment. Thus, each individual point reflects the collective data from an experiment involving 10 vaccinated and 10 CT mice (n = 203). Lower normalized CFU values indicate enhanced bacterial clearance after challenge, where higher class switch indices represent superior B cell activation by comparing the increase in IgG compared to the increase in IgM. (B) Normalized bladder CFU values from each vaccination experiment are plotted against the median change in absorbance of antigen-specfic IgA detected in the urine (ΔIgAVAC). Pearson correlation coefficient (r) and P values are shown.](https://figures.cochat.ai/paper-figures/4ade885dc2df4b6abbe6fe8de5cd08ec/mucosal-immunization-with-iron-receptor-antigens-protects-against-urinary-tract-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, Alteri et al. used a large-scale vaccinology approach to identify candidate uropathogenic E. coli vaccine antigens and found that immunization with six outer membrane iron receptors protected against UTI (Alteri et al., 2009).”
From Iron in infection and immunity (2013) · cites this paper as Alteri et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
INDUCTION OF TH1 AND TH2 CD4+T CELL RESPONSES:The Alternative Approaches
Constant, S. L., & Bottomly, K. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.297 · Cited by 1,459
Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing
Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,399
Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract.
Connell, I., Agace, W., Klemm, P., Schembri, M., Mărild, S., & Svanborg, C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9827 · Cited by 735
Gupta, K., Hooton, T. M., & Stamm, W. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-1-200107030-00012 · Cited by 677
Crystal structure of the outer membrane active transporter FepA from Escherichia coli.
Buchanan (1999) · Nature Structural Biology · doi:10.1038/4931 · Cited by 591
Prevention of Mucosal Escherichia coli Infection by FimH-Adhesin-Based Systemic Vaccination
Langermann, S., Palaszynski, S., Barnhart, M., Auguste, G., Pinkner, J. S., Burlein, J., Barren, P., Koenig, S., Leath, S., Jones, C. H., et al. (1997) · Science · doi:10.1126/science.276.5312.607 · Cited by 577
Mobley, H. L., Green, D. M., Trifillis, A. L., Johnson, D. E., Chippendale, G. R., Lockatell, C. V., Jones, B. D., & Warren, J. W. (1990) · Infection and Immunity · doi:10.1128/iai.58.5.1281-1289.1990 · Cited by 561
Self-citationUmemura, M., Yahagi, A., Hamada, S., Begum, M. D., Watanabe, H., Kawakami, K., Suda, T., Sudo, K., Nakae, S., Iwakura, Y., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.6.3786 · Cited by 519
Shibata, K., Yamada, H., Hara, H., Kishihara, K., & Yoshikai, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4466 · Cited by 483
Interleukin-17 and Lung Host Defense against Klebsiella pneumoniae Infection
Ye, P., Garvey, P. B., Zhang, P., Nelson, S., Bagby, G., Summer, W. R., Schwarzenberger, P., Shellito, J. E., & Kolls, J. K. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.3.4424 · Cited by 461
Recurring urinary tract infection: incidence and risk factors.
Foxman, B. (1990) · American Journal of Public Health · doi:10.2105/ajph.80.3.331 · Cited by 435
Urinary Tract Infections: Molecular Pathogenesis and Clinical Management
Mobley, H. L. T., & Warren, J. W. (1996) · Medical Entomology and Zoology · Cited by 391
Self-citationInduction, function and regulation of IL‐17‐producing T cells
Mills, K. H. G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838535 · Cited by 385
Transcriptome of Uropathogenic Escherichia coli during Urinary Tract Infection
Snyder, J. A., Haugen, B. J., Buckles, E. L., Lockatell, C. V., Johnson, D. E., Donnenberg, M. S., Welch, R. A., & Mobley, H. L. T. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6373-6381.2004 · Cited by 381
Self-citationHagberg, L., Engberg, I., Freter, R., Lam, J., Olling, S., & Svanborg Edén, C. (1983) · Infection and Immunity · doi:10.1128/iai.40.1.273-283.1983 · Cited by 362
Hamada, S., Umemura, M., Shiono, T., Tanaka, K., Yahagi, A., Begum, M. D., Oshiro, K., Okamoto, Y., Watanabe, H., Kawakami, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3456 · Cited by 353
UROLOGIC DISEASES IN AMERICA PROJECT: TRENDS IN RESOURCE USE FOR URINARY TRACT INFECTIONS IN MEN
GRIEBLING, T. L. (2005) · Journal of Urology · doi:10.1097/01.ju.0000155595.98120.8e · Cited by 351
Langermann, S., Möllby, R., Burlein, J. E., Palaszynski, S. R., Auguste, C. G., DeFusco, A., Strouse, R., Schenerman, M. A., Hultgren, S. J., Pinkner, J. S., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315258 · Cited by 336
Torres, A. G., Redford, P., Welch, R. A., & Payne, S. M. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.6179-6185.2001 · Cited by 287
Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli
Johnson, J. R., & Russo, T. A. (2005) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2005.07.005 · Cited by 286
UROLOGIC DISEASES IN AMERICA PROJECT: TRENDS IN RESOURCE USE FOR URINARY TRACT INFECTIONS IN WOMEN
GRIEBLING, T. L. (2005) · Journal of Urology · doi:10.1097/01.ju.0000155596.98780.82 · Cited by 265
UROLOGIC DISEASES IN AMERICA PROJECT: ANALYTICAL METHODS AND PRINCIPAL FINDINGS
LITWIN, M. S., SAIGAL, C. S., YANO, E. M., AVILA, C., GESCHWIND, S. A., HANLEY, J. M., JOYCE, G. F., MADISON, R., PACE, J., POLICH, S. M., et al. (2005) · Journal of Urology · doi:10.1097/01.ju.0000152365.43125.3b · Cited by 254
Defining Genomic Islands and Uropathogen-Specific Genes in Uropathogenic Escherichia coli
Lloyd, A. L., Rasko, D. A., & Mobley, H. L. T. (2007) · Journal of Bacteriology · doi:10.1128/jb.01744-06 · Cited by 246
Self-citationBauer, H. W., Alloussi, S., Egger, G., Blümlein, H.-M., Cozma, G., & Schulman, C. C. (2005) · European Urology · doi:10.1016/j.eururo.2004.12.009 · Cited by 166
Uropathogenic Escherichia coli Outer Membrane Antigens Expressed during Urinary Tract Infection
Hagan, E. C., & Mobley, H. L. T. (2007) · Infection and Immunity · doi:10.1128/iai.00337-07 · Cited by 159
Self-citationReigstad, C. S., Hultgren, S. J., & Gordon, J. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611502200 · Cited by 152
Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection
Lin, K.-Y., Chiu, N.-T., Chen, M.-J., Lai, C.-H., Huang, J.-J., Yu-Tai, W., & Chiou, Y. (2003) · Pediatric Nephrology · doi:10.1007/s00467-003-1109-1 · Cited by 147
Hacker, J. H., Knapp, S., & Goebel, W. (1983) · Journal of Bacteriology · doi:10.1128/jb.154.3.1145-1152.1983 · Cited by 140
Schulz, S. M., Kohler, G., Holscher, C., Iwakura, Y., & Alber, G. (2008) · International Immunology · doi:10.1093/intimm/dxn069 · Cited by 139
Hagan, E. C., & Mobley, H. L. T. (2009) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06509.x · Cited by 135
Self-citationHopkins, W. J., Elkahwaji, J. E., Beierle, L. M., LEVERSON, G. E., & Uehling, D. T. (2007) · The Journal of Urology · doi:10.1016/j.juro.2006.11.093 · Cited by 135
Russo, T. A., Carlino, U. B., & Johnson, J. R. (2001) · Infection and Immunity · doi:10.1128/iai.69.10.6209-6216.2001 · Cited by 130
Russo, T. A., McFadden, C. D., Carlino-MacDonald, U. B., Beanan, J. M., Barnard, T. J., & Johnson, J. R. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.7156-7160.2002 · Cited by 127
O'Hanley, P. D., Lalonde, G., & Ji, G. (1991) · Infection and Immunity · doi:10.1128/iai.59.3.1153-1161.1991 · Cited by 127
Johnson, J. R., Jelacic, S., Schoening, L. M., Clabots, C., Shaikh, N., Mobley, H. L. T., & Tarr, P. I. (2005) · Infection and Immunity · doi:10.1128/iai.73.2.965-971.2005 · Cited by 121
Self-citationAlteri, C. J., & Mobley, H. L. T. (2007) · Infection and Immunity · doi:10.1128/iai.00076-07 · Cited by 121
Self-citationPhase 2 Clinical Trial of a Vaginal Mucosal Vaccine for Urinary Tract Infections
Uehling, D. T., Hopkins, W. J., Elkahwaji, J. E., SCHMIDT, D., & LEVERSON, G. E. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000075094.54767.6e · Cited by 117
ROBERTS, J. A., KAACK, M. B., BASKIN, G., CHAPMAN, M. R., HUNSTAD, D. A., PINKNER, J. S., & HULTGREN, S. J. (2004) · Journal of Urology · doi:10.1097/01.ju.0000116123.05160.43 · Cited by 106
Alteri, C. J., & Mobley, H. L. T. (2007) · Infection and Immunity · doi:10.1128/iai.00076-06 · Cited by 102
Self-citationRusso, T. A., McFadden, C. D., Carlino-MacDonald, U. B., Beanan, J. M., Olson, R., & Wilding, G. E. (2003) · Infection and Immunity · doi:10.1128/iai.71.12.7164-7169.2003 · Cited by 93
Durant, L., Métais, A., Soulama-Mouze, C., Genevard, J.-M., Nassif, X., & Escaich, S. (2006) · Infection and Immunity · doi:10.1128/iai.01269-06 · Cited by 75
Development of an Intranasal Vaccine To Prevent Urinary Tract Infection byProteus mirabilis
Li, X., Lockatell, C. V., Johnson, D. E., Lane, M. C., Warren, J. W., & Mobley, H. L. T. (2003) · Infection and Immunity · doi:10.1128/iai.72.1.66-75.2004 · Cited by 72
Self-citationSUSCEPTIBILITY OF IMMUNODEFICIENT GENE-KNOCKOUT MICE TO URINARY TRACT INFECTION
Jones‐Carson, J., Balish, E., & Uehling, D. T. (1999) · The Journal of Urology · doi:10.1016/s0022-5347(01)62142-6 · Cited by 71
Plainvert, C., Bidet, P., Peigne, C., Barbe, V., Médigue, C., Denamur, É., Bingen, É., & Bonacorsi, S. (2007) · Journal of Bacteriology · doi:10.1128/jb.01013-07 · Cited by 54
Goluszko, P., Goluszko, E., Nowicki, B. J., Nowicki, S., Popov, V., & Wang, H.-Q. (2004) · Infection and Immunity · doi:10.1128/iai.73.1.627-631.2005 · Cited by 47
Lescat, M., Calteau, A., Hoede, C., Barbe, V., Touchon, M., Rocha, E. P. C., Tenaillon, O., Médigue, C., Johnson, J. R., & Denamur, É. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00123-09 · Cited by 41
Russo, T. A., Beanan, J. M., Olson, R., Genagon, S. A., MacDonald, U., Cope, J. J., Davidson, B. A., Johnston, B., & Johnson, J. R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.100 · Cited by 38
Nayır, A., Emre, S., Şirin, A., Bulut, A., Alpay, H., & Tanman, F. (1995) · Vaccine · doi:10.1016/0264-410x(95)00022-s · Cited by 28
Layton, G. T., & Smithyman, A. M. (1983) · PubMed · Cited by 28
Protection by a polyvalent vaccine against challenge infection and pyelonephritis
Kruze, D., Biro, K. S., Holzbecher, K., Andrial, M., & Bossart, W. (1992) · Urological Research · doi:10.1007/bf00296534 · Cited by 27
Hopkins, W. J., & Uehling, D. T. (1995) · Urology · doi:10.1016/s0090-4295(95)96444-4 · Cited by 19
Kantele, A., Palkola, N. V., Arvilommi, H. S., & Kantele, J. M. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.05.003 · Cited by 17
Kumar, V., Ganguly, N. K., Joshi, K., Mittal, R., Harjai, K., Chhibber, S., & Sharma, S. (2005) · Medical Microbiology and Immunology · doi:10.1007/s00430-005-0241-x · Cited by 10
Sträube, E., Nimmich, W., Broschewitz, U., & Naumann, G. (1986) · PubMed · Cited by 4
Straube, E., Nimmich, W., Broschewitz, U., Naumann, G., & Hacker, K. (1987) · Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology · doi:10.1016/s0176-6724(87)80260-2 · Cited by 4
Cited by
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3432 · Cited by 4,213
Iron in infection and immunity
Cassat, J. E., & Skaar, E. P. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.04.010 · Cited by 1,214
The Battle for Iron between Bacterial Pathogens and Their Vertebrate Hosts
Skaar, E. P. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000949 · Cited by 796
“coli iron acquisition proteins [24] are examples of iron utilization systems that have been proposed as candidate vaccines.”
BackgroundHost–pathogen interactions in urinary tract infection
Nielubowicz, G. R., & Mobley, H. L. T. (2010) · Nature Reviews Urology · doi:10.1038/nrurol.2010.101 · Cited by 471
Self-citationProteus mirabilis and Urinary Tract Infections
Schaffer, J. N., & Pearson, M. M. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.uti-0017-2013 · Cited by 399
Metadata
- Authors
- Alteri, C. J., Hagan, E. C., Sivick, K. E., Smith, S. N., & Mobley, H. L. T.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Mobley, Harry L. T.
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-09-18
- Volume
- 5
- Issue
- 9
- Pages
- e1000586
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2736566
- OpenAlex
- W2136361919
- Cited by
- 201
- References
- 55
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 5 · 2023: 18 · 2022: 5 · 2021: 12 · 2020: 11 · 2019: 8 · 2018: 11 · 2017: 7 · 2016: 18 · 2015: 20 · 2014: 17 · 2013: 11 · 2012: 12
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (T32GM145304)
- National Institute of Allergy and Infectious Diseases (R01AI043363, R56AI043363, AI043363)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Health Sciences › Medicine › Urology › Urinary Tract Infections Management
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Keywords
- urinary tract infection, uropathogenic Escherichia coli, mucosal immunization, intranasal vaccine, iron acquisition, outer membrane receptor, vaccine candidate selection, HMA, iutA, iron, iha, chuA, IgA, IgG, interferon-gamma, IL-17, bladder colonization, subunit vaccine, CFT073
- MeSH terms
- Administration, Intranasal, Animals, Antibodies, Bacterial, Antigens, Bacterial, Cells, Cultured, Escherichia coli, Escherichia coli Infections, Female, Immunoglobulin A, Secretory, Interferon-gamma, Mice, Inbred CBA, Recombinant Fusion Proteins, Spleen, Urinary Tract Infections, Immunoglobulin Class Switching, Statistics, Nonparametric, Interleukin-17, Escherichia coli Vaccines, Escherichia coli Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.